Our Clinical Research Partners
Over the last 18 years, CMB Clinical Trials has worked with a variety of clinical partners, pharmaceutical companies, and biotech companies throughout the nation. Working with our partners, such as Pfizer, Teva Pharmaceuticals Industries, Otsuka Pharmaceuticals, and Shire Pharmaceuticals, we could conduct over 400 inpatient and outpatient studies ranging from schizophrenia research trials to diabetes research trials.
Pfizer Inc. is an American multinational pharmaceutical company headquartered in New York City, with its research headquarters in Groton, Connecticut. It ranks among one of the world’s largest companies in pharmacy. The pharmaceutical company has been developing vaccines and medications for several medical disciplines, including oncology, immunology, neurology, cardiology, and endocrinology.
Teva Pharmaceuticals Industries
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company headquartered in Petah Tikva, Israel. It specializes mostly in generic medicines, but additional business interests involve active pharmaceutical components and, to a minor degree, select pharmaceuticals.
Otsuka is at the lead of redefining the clinical trial methods to increase convenience and achieve further accurate and targeted data more quickly. If we can get results and seek approvals rapidly, we can eventually forward the treatments to the hands of doctors and their patients earlier.
Shire was a global biotechnology company primarily focusing on serving individuals who have highly rare and specialized conditions. The products of the company were available in over 100 countries across core therapeutic areas, including Immunology, Hematology, Gastrointestinal, Lysosomal Storage Disorders, Endocrine, and Hereditary Angioedema.